Siemens' solutions for the pharmaceutical industry supports you in winning the race against time against the Corona virus

Let’s stand together against COVID-19

In the fight against the coronavirus, pharmaceutical companies around the world try to win the race against time to end the pandemic. We’re here to support you.
Let us know how we can support you!

Contact us

Reduce time to market

Improving the process in pre-clinical and clinical phases

There is no greater work being done in the world right now than finding potential treatments and vaccines for the coronavirus disease known as COVID-19. Around the world, numerous companies are working on antiviral drugs, on antibodies and on other treatments. Among them are many of our customers, who we continue to support in finding solutions to this current crisis.
Siemens is supporting the pharmaceutical industry by creating a task force to fast track and adapt solutions to accelerate the entire value chain of research, development and manufacture of new therapeutics and new vaccines.
Rebecca Vangenechten, Siemens AG

Acceleration from development to manufacturing to patient

Ramping up production in the quantities needed and accelerating clinical trials in the timeframes required to combat COVID-19 is one of the biggest challenges the industry has ever faced. You have turned to Siemens as your trusted partner in the past for the reliable manufacture of products, as well as the design and simulation of new processes, and our Siemens team is ready to be turned to again, to help you accelerate your manufacturing capabilities.

Virtual Summit 2020

Accelerate for the next level of pharma

New diseases require new medications, and growing competition calls for faster, leaner processes in all areas of business in pharmaceutical companies. Digitalizing pharmaceutical plants helps shorten market launch times and improve quality even more. Digital Enterprise is the comprehensive portfolio from Siemens for the digital transformation with solutions for the specific requirements of the pharmaceutical industry.

 

Rebecca Vangenechten, head of Pharma at Siemens, discusses with Christos Varsakelis from GSK, how new tools like digital twins can support process development and production and how proven solutions can help accelerate R&D and manufacturing in the pharmaceutical industry.

It’s time to save time

How we can win the race against time

R&D can take years, but the fight against COVID-19 needs to be sped up. The holistic Digital Twin from Siemens' Digital Enterprise portfolio enables pharmaceutical companies to accelerate R&D, reduce time to market, and scale-up production faster.

Faster from the lab to market with the digital twin concept

With the digital twin concept, we are able to use different technologies to create a virtual world in which the research and development for new therapies and vaccines can be accelerated. To speed it up we established a new Siemens Business with Process Systems Enterprise (PSE) that enables to optimize your plant’s productivity and performance using predictive models that faithfully reflect the real thing.

 

For example, a new process can be modeled with gPROMS software and extensively tested and simulated. With the help of our complete multiphysics simulation solution Star-CCM+ it becomes possible to simulate the material flow within a bioreactor.

Design for global scale up 

Automation and digitalization solutions help to accelerate the production process for optimal upscaling. The COMOS plant engineering software enables to build modular and flexible plants in order to achieve rapid design and commissioning of production lines. Modular plant design also increases flexibility and speed to quickly adapt to new requirements. For example, machine and plant manufacturer GEA is using technology from Siemens and the module type package (MTP) industry standard to build specific modules for the pharmaceutical industry that can be easily integrated into existing plants.  

 

Standardization is also important to optimally process big data from bioprocesses, which becomes possible with Siemens BioMAC. This cloud-based data processing and analytics offering helps companies to break silos and empower manufacturing teams with data-driven decision making.

Ensure operation with reliable support and services

The world as we know it has changed and we are all facing new challenges caused by the COVID-19 pandemic. In order to support your business, Siemens Industry Service are here to you support you, while protecting your employees as well as ours. Please contact us and let us know how we can help you. You can find an overview of our service offerings during these challenging times on a dedicated website. We also continue to provide web-based training via SITRAIN access and SITRAIN open.

Success stories

End-to-end solutions in practice

Automation and digitalization, simulation and standardization: Our proven end-to-end solution support pharmaceutical companies around the world to enhance their R&D, reduce time from lab to production, speed up their processes, and maintain highest quality throughout their entire value chain.

How Siemens fights COVID-19 across the entire company

Find out, how Siemens deals with the COVID-19 pandemic in order to protect the health and safety of its employees while at the same time supporting its partners, customers, and society.

Contact

We’re here to support you to win the race against time

Let us know how we can support with your fight against COVID-19. No matter if you’re working on a vaccine or a new drug to help patients, our experts are here to support you.